Briacell Therapeutics Corp NEW (BCTX) Earnings Date & Reports

BriaCell Therapeutics Corp is a clinical-stage biotechnology company focused on developing immunotherapies for cancer treatment, particularly breast cancer... Show more

Get AI intraday signals

A.I. Advisor

published Earnings

BCTX is expected to report earnings to rise 171.43% to -208 cents per share on October 22

Briacell Therapeutics Corp NEW BCTX Stock Earnings Reports

Q3'26

Est.

$-2.09

Q1'23

Missed

by $0.41

Q4'22

Beat

by $0.26

Q3'22

Missed

by $0.74

Q2'22

Missed

by $0.11

The last earnings report on March 16 showed earnings per share of -76 cents, missing the estimate of -35 cents. With 46.07K shares outstanding, the current market capitalization sits at 26.16M.

View a ticker or compare two or three

Compare

BCTX

Setup

Daily Signal:

Description

Gain/Loss:

Interact to see
Advertisement

A.I.Advisor

published price charts

Last 5 trading days

View AI-Driven Trading for BCTX